FDA RESUME - Unknown Company

**FDA Inspection Summary: Cedarburg Pharmaceuticals**

**Company Name:** Cedarburg Pharmaceuticals, Grafton, Wisconsin, USA

**Inspection Dates:** Not specified in the document.

**Main Violations/Issues:** The document outlines various quality control and assurance responsibilities held by the individual at Cedarburg Pharmaceuticals, indicating a focus on compliance with FDA guidelines and cGMP standards. However, specific violations or issues identified during FDA inspections are not detailed in the provided text.

**Regulatory Framework:** The operations at Cedarburg Pharmaceuticals are governed by FDA guidelines and current Good Manufacturing Practices (cGMP). The company is responsible for ensuring compliance through rigorous quality control and assurance processes, including raw material and finished product testing, stability programs, and internal audits.

**Required Actions:** While specific corrective actions required by the FDA are not mentioned, the document highlights the company's proactive measures to maintain compliance. These include hiring new leadership for quality control, establishing a stability position, and employing a regulatory specialist to ensure high compliance levels. The company also conducts regular internal audits and provides cGMP training for all employees to uphold quality standards.

**Summary:** Cedarburg Pharmaceuticals is committed to maintaining high-quality standards and compliance with FDA regulations. The company has implemented various quality control and assurance measures, including oversight of testing, audits, and training programs. While specific FDA inspection findings are not detailed, the company's focus on regulatory compliance and continuous improvement is evident.